Skip to Main Content

Spotlight, January 2026

Published
Topics: Monthly digest

A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for January 2026.

Events

Managing medicines inventory in hospital pharmacy

Tools and user guides for NHS Trusts to optimally manage medicines inventory.

SMRs in problematic polypharmacy: diabetes focus

Consultant pharmacists will use a case study to illustrate a patient centred approach to SMRs for patients with diabetes.

SMRs in problematic polypharmacy: cardiovascular disease focus

Consultant pharmacists will use a case study to illustrate a patient centred approach to SMRs for patients with cardiovascular disease.

Updated clinical trials regulation: implementation considerations

An SPS Quality Assurance learning event on understanding the updated clinical trials regulation and practical considerations for pharmacy clinical trials sites.

New Guidance

New articles published to the website during January 2026.

Aseptic Services

Aseptic services

All our resources for pharmacy aseptic services.

Understanding aseptic services in the NHS

Pharmacy aseptic services make ready-to-administer injectable medicines to ensure safe and timely treatment for patients.

Assuring quality in NHS aseptic services

Application of quality assurance principles ensures the safe, effective, and reliable preparation of injectable medicines by NHS pharmacy aseptic services.

Regulations for NHS aseptic services

NHS pharmacy aseptic services are tightly regulated to maintain high standards and ensure patient safety.

Introduction to aseptic manipulation of injectable medicines

Manipulation of injectable medicines is a high-risk activity. Risks and controls differ between clinical areas and pharmacy aseptic units.

Procurement

Managing medicines inventory

Approaches to maintain accurate medicines inventory and investigate incorrect stock levels by secondary care pharmacy procurement teams.

Understanding principles of medicines inventory management

Our advice to help NHS secondary care pharmacy procurement teams manage inventory of medicines.

Completing regular and annual stock checks

Emphasising the value in committing time to robust stock management processes

Reconciling stock in automated storage systems

Highlighting the importance of maintaining a closed system, monitoring and restricting access to minimise errors and discrepancies.

Monitoring slow moving stock and rarely used medicines

It is important to hold medicines in date and identify where usage of medicines has changed or are only required on an irregular basis.

Managing high value medicines

Medicines can be seen as a liability or an asset. High value medicines should have regular stock checks to ensure stock holding is accurate.

Managing stock of critical medicines

Essential medicines that must be held in stock or risk assessed for alternatives if unavailable.

Managing high frequency order lines

Advice on optimising pharmacy systems to balance storage capacity, supply and demand.

Managing expired stock and decommissioned products

Advice on how to manage expired stock and decommissioning of medicines.

Updated Guidance

Articles updated and reviewed in January 2026.

Biosimilars

Preparing to use omalizumab biosimilar

One omalizumab biosimilar (Omlyclo) is available and other biosimilars are in development. We offer general information and implementation advice.

The licence and supporting evidence for omalizumab biosimilar

One omalizumab biosimilar is currently available: Omlyco. Learn about the licensed indications, available preparations, supporting evidence and key differences.

PGDs

Patient Specific Directions (PSD)

This article describes Patient Specific Directions and the requirements for their writing and use

Understanding why PGDs cannot be used for dose adjustments

This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession.

Using medicines at more than one location under a single PGD

A single Patient Group Direction (PGD) can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.

Use of PGDs by trainee registered healthcare professionals

Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment

Understanding roles and responsibilities of PGD signatories

Advice to support signatories of Patient Group Direction (PGD) in understanding their responsibilities when undertaking this role

Other

Avoid prescribing desiccated (natural) thyroid extract

Levothyroxine is the recommended treatment for hypothyroidism. Desiccated or natural thyroid extracts (DTE) should not be prescribed in primary care.

Switching between gabapentin and pregabalin for neuropathic pain

An overview of possible dose equivalences, switching methods and considerations to make before switching between immediate-release gabapentinoids.

Advising on specific medicines following bariatric surgery

Guidance to inform prescribing decisions, following the effects bariatric surgery can have on medicines.

Assessing injectables for enteral administration

Clinical decisions on the use of injectable formulations for enteral administration should be guided by safety and practicality.

Updated PGDs

Updated versions of the following PGDs have been published to allow organisations to undertake local governance processes in a timely manner (valid from April or May 2026)

Medroxyprogesterone acetate (DMPA) IM injection for contraception

SPS PGD template for administering intramuscular (IM) medroxyprogesterone acetate (DMPA) injection for contraception.

Medroxyprogesterone acetate (SC-DMPA) injection for contraception

SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection for contraception.

Combined oral hormonal contraceptive (COC) in reproductive health

SPS PGD template for the supply of a combined oral hormonal contraceptive for contraception, or for individuals requiring control of problematic bleeding.

Combined hormonal contraceptive vaginal ring

SPS PGD template for the supply of combined hormonal vaginal ring for contraception.

Combined hormonal contraceptive transdermal patch

SPS PGD template for the supply of combined hormonal transdermal patch for contraception.

Publications

New Medicines News

New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.

Shortages

Medicines Supply Tool

Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and MVA team, NHS England.